美国代谢综合征与卵巢癌及输卵管癌风险:基于SEER-Medicare关联数据的分析
基于美国SEER-Medicare关联数据库的病例对照研究(病例16850例,对照281878例)显示,符合代谢综合征诊断标准的女性卵巢癌风险降低(OR 0.86,95%CI 0.82-0.89);空腹血糖受损与风险降低相关(OR 0.90,95%CI 0.87-0.93),高血压和高甘油三酯与风险升高相关(OR 1.08,95%CI 1.04-1.12;OR 1.05,95%CI 1.01-1.08)。作者认为代谢综合征各组分与卵巢癌的关联方向不一,将代谢综合征作为复合暴露评估可能产生误导,但需进一步研究各组分。
要点
- 符合代谢综合征诊断标准者卵巢癌风险降低(OR 0.86,95%CI 0.82-0.89)。
- 空腹血糖受损与风险降低相关(OR 0.90,95%CI 0.87-0.93)。
- 高血压和高甘油三酯分别与风险升高相关(OR 1.08,95%CI 1.04-1.12;OR 1.05,95%CI 1.01-1.08)。
核心结论
- 特定代谢综合征组分与卵巢癌可能存在 modest 关联,关联方向不一。
- 各组分的患病率影响代谢综合征与卵巢癌的总体关联。
- 在卵巢癌研究中将代谢综合征作为复合暴露评估可能产生误导,但需进一步研究该综合征各组分。
研究设计与样本
- 基于美国SEER-Medicare关联数据库的病例对照研究。
- 病例为1994年至2013年间诊断为癌症、年龄68-89岁的女性(n=16,850)。
- 对照为注册地区内无这些癌症的Medicare参保者(n=281,878)。
- 采用逻辑回归估计调整后的比值比(OR)和95%置信区间(CI)。
主要发现
- 符合代谢综合征诊断标准的女性较不符合诊断标准者卵巢癌风险降低(OR 0.86,95%CI 0.82-0.89)。
- 与无任何组分的女性相比,有1个或2个综合征组分与风险升高相关,有≥3个组分则与风险升高不相关。
- 空腹血糖受损在代谢综合征患者中高度流行,与风险降低相关(OR 0.90,95%CI 0.87-0.93)。
- 高血压和高甘油三酯是无代谢综合征女性中最流行的组分,分别与风险升高相关(OR 1.08,95%CI 1.04-1.12;OR 1.05,95%CI 1.01-1.08)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To clarify associations between metabolic syndrome, its components, and ovarian cancer risk. METHODS: Using a case-control study within the U.S.-based Surveillance, Epidemiology and End Results (SEER)-Medicare linked database, we examined metabolic syndrome, its components (obesity, impaired fasting glucose, hypertension, HDL cholesterol, triglycerides), and ovarian/fallopian tube cancer risk. Cases (n = 16,850) were diagnosed with cancer between age 68-89 from 1994 through 2013. Controls (n = 281,878) were Medicare enrollees without these cancers living in registry areas. We estimated adjusted odds ratios (OR) and 95% confidence intervals (CI) with logistic regression. RESULTS: Women with metabolic syndrome had reduced ovarian cancer risk compared to women not meeting the diagnostic criteria (OR 0.86, CI 0.82-0.89). Having one or two syndrome components was associated with increased risk, but having ≥3 was not, when compared to women without any components. Impaired fasting glucose, which was highly prevalent among those with metabolic syndrome, was associated with reduced risk (OR 0.90, CI 0.87-0.93). Hypertension and high triglycerides, the most prevalent components among women without metabolic syndrome, were associated with increased risks (OR 1.08, CI 1.04-1.12; OR 1.05, CI 1.01-1.08, respectively). CONCLUSIONS: Specific metabolic syndrome components may have modest associations with ovarian cancer. These associations varied in direction and the prevalence of the components influenced the overall association between metabolic syndrome and ovarian cancer. Evaluating metabolic syndrome as a composite exposure could be misleading in ovarian cancer research, but further study of the syndrome components is warranted.
引用
- Michels KA, McNeel TS, Trabert B, et al. Metabolic syndrome and risk of ovarian and fallopian tube cancer in the United States: An analysis of linked SEER-Medicare data. Gynecol Oncol. 2019. PMID: 31495456. doi:10.1016/j.ygyno.2019.08.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。